Codexis To Participate In Upcoming Investor Conferences

Codexis, Inc. (NASDAQ:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the company will be participating in the following upcoming investor conferences:

JMP Securities 11 th Annual Research ConferenceDate: Monday, May 14 thTime: 8:30am PTLocation: San Francisco, CASpeaker: Peter Strumph, Interim CEO

Deutsche Bank 2012 Clean Tech, Utilities & Power ConferenceDate: Tuesday, May 15thTime: 1:35pm ETLocation: New York, NYSpeaker: Peter Strumph, Interim CEO

Webcasts and replays of the company presentations will be available in the Investor section of www.codexis.com

About Codexis, Inc.

Codexis, Inc. is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates. Codexis' product lines include CodeXyme™ Cellulase Enzymes and CodeXol™ Detergent Alcohol. Partners and customers include global leaders such as Shell, Merck and Pfizer. For more information, see www.codexis.com.

Copyright Business Wire 2010